MDM2 and cancer: Relatively low dose (0.4 Gy) of gamma-radiation was shown to affect cellular functions such as cell death, cancer, and p53 signaling pathways; however, some important p53 downstream target genes such as CDKN1A and HDM2 were identified as being nonresponsive to 0.4 Gy.